Skip to main content

Viviad

A phase IIb trial, multicenter, randomized, double-blind, placebo-controlled study of the safety, tolerability and efficacy…
10 December 2020

DIAN-TU

A phase II / III, multicenter, randomized, double-blind controlled trial. The aim is to learn…
8 December 2020

Anavex

A phase IIb / III, double-blind, randomized, placebo-controlled study on the safety and effectiveness of…
7 December 2020

AC Immune

Phase Ib / IIa, multicentre, randomized, double-blind, placebo-controlled study. The study examines the safety, tolerability,…
6 December 2020

CogRX

Phase II study, single center, randomized, double blind, placebo controlled. The study will investigate the…
5 December 2020

Gain

Phase II / III, randomized, double-blind, placebo-controlled study. With this study, the researchers want to…
4 December 2020

EU201

Phase II trial, multicenter, randomized, double-blind, placebo-controlled. The research drug T-817MA is a new drug…
3 December 2020

Graduate

Phase III, multicenter, randomized, double-blind, placebo-controlled study. The research drug Gantenerumab is a new drug…
2 December 2020

Ionis

The research drug ISIS 814907 is a new drug that is being developed against Alzheimer's…
1 December 2020